571 hedge funds and large institutions have $8.71B invested in Sanofi in 2020 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 200 increasing their positions, 202 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

5% less capital invested

Capital invested by funds: $9.15B → $8.71B (-$441M)

8% less first-time investments, than exits

New positions opened: 49 | Existing positions closed: 53

2% less funds holding

Funds holding: 580571 (-9)

Holders
571
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$37.7M
Puts
$17M
Net Calls
Net Calls Change

Top Buyers

1 +$26M
2 +$23.5M
3 +$13.5M
4
Citigroup
Citigroup
New York
+$12M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$8.3M
Name Holding Trade Value Shares
Change
Change in
Stake
351
$310K
352
$310K
353
$308K
354
$308K
355
$307K
356
$306K
357
$305K
358
$303K
359
$302K
360
$302K
361
$301K
362
$300K
363
$287K
364
$287K
365
$286K
366
$282K
367
$282K
368
$281K
369
$281K
370
$279K
371
$277K
372
$275K
373
$275K
374
$274K
375
$274K